NZ179733A - Stable insulin preparation - Google Patents

Stable insulin preparation

Info

Publication number
NZ179733A
NZ179733A NZ179733A NZ17973376A NZ179733A NZ 179733 A NZ179733 A NZ 179733A NZ 179733 A NZ179733 A NZ 179733A NZ 17973376 A NZ17973376 A NZ 17973376A NZ 179733 A NZ179733 A NZ 179733A
Authority
NZ
New Zealand
Prior art keywords
insulin preparation
stable insulin
stable
preparation
insulin
Prior art date
Application number
NZ179733A
Other languages
English (en)
Inventor
B Hansen
F Andresen
Original Assignee
Nordisk Insulinlab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordisk Insulinlab filed Critical Nordisk Insulinlab
Publication of NZ179733A publication Critical patent/NZ179733A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • C07K14/625Extraction from natural sources
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NZ179733A 1975-01-15 1976-01-12 Stable insulin preparation NZ179733A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK8375AA DK140801B (da) 1975-01-15 1975-01-15 Fremgangsmåde til fremstilling af et stabilt langtidsvirkende insulinpræparat.

Publications (1)

Publication Number Publication Date
NZ179733A true NZ179733A (en) 1978-04-28

Family

ID=8089535

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ179733A NZ179733A (en) 1975-01-15 1976-01-12 Stable insulin preparation

Country Status (36)

Country Link
JP (1) JPS5946939B2 (xx)
AR (1) AR213088A1 (xx)
AT (1) AT362492B (xx)
BE (1) BE837600A (xx)
BR (1) BR7600206A (xx)
CA (1) CA1094549A (xx)
CH (1) CH631625A5 (xx)
CS (1) CS208147B2 (xx)
DD (1) DD124379A5 (xx)
DE (1) DE2600971C2 (xx)
DK (1) DK140801B (xx)
EG (1) EG11988A (xx)
ES (1) ES444558A1 (xx)
FI (1) FI66751C (xx)
FR (1) FR2297634A1 (xx)
GB (1) GB1524431A (xx)
GR (1) GR58608B (xx)
HU (1) HU175142B (xx)
IE (1) IE42395B1 (xx)
IL (1) IL48845A (xx)
IN (1) IN143279B (xx)
IT (1) IT1054211B (xx)
KE (1) KE2919A (xx)
LU (1) LU74175A1 (xx)
MX (1) MX4052E (xx)
MY (1) MY7900169A (xx)
NL (1) NL166464C (xx)
NO (1) NO146698C (xx)
NZ (1) NZ179733A (xx)
OA (1) OA05209A (xx)
PL (1) PL99927B1 (xx)
PT (1) PT64696B (xx)
RO (1) RO71576A (xx)
SE (1) SE437219B (xx)
YU (1) YU8376A (xx)
ZA (1) ZA7658B (xx)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK374579A (da) * 1979-09-07 1981-03-08 Nordisk Insulinlab Fremgangsmaade til fremstilling af et injucerbart insulinpraeparat
US4459226A (en) * 1982-02-26 1984-07-10 Eli Lilly And Company Process for recovering insulin
US4801575A (en) * 1986-07-30 1989-01-31 The Regents Of The University Of California Chimeric peptides for neuropeptide delivery through the blood-brain barrier
US4878892A (en) * 1987-02-10 1989-11-07 Drug Delivery Systems Inc. Electrolytic transdermal delivery of polypeptides
AU609769B2 (en) * 1987-02-10 1991-05-09 Drug Delivery Systems Inc. Electrolytic transdermal delivery of proteins
US5714167A (en) 1992-06-15 1998-02-03 Emisphere Technologies, Inc. Active agent transport systems
US5629020A (en) * 1994-04-22 1997-05-13 Emisphere Technologies, Inc. Modified amino acids for drug delivery
US6221367B1 (en) 1992-06-15 2001-04-24 Emisphere Technologies, Inc. Active agent transport systems
US5447728A (en) 1992-06-15 1995-09-05 Emisphere Technologies, Inc. Desferrioxamine oral delivery system
US5643957A (en) 1993-04-22 1997-07-01 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5750147A (en) 1995-06-07 1998-05-12 Emisphere Technologies, Inc. Method of solubilizing and encapsulating itraconazole
US6051258A (en) 1995-06-07 2000-04-18 Emisphere Technologies, Inc. Proteinoid emulsions and methods for preparation and use thereof
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
US10011906B2 (en) 2009-03-31 2018-07-03 Beohringer Ingelheim International Gmbh Method for coating a surface of a component
EP3508239B1 (de) 2009-05-18 2020-12-23 Boehringer Ingelheim International GmbH Adapter, inhalationseinrichtung und zerstäuber
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011064164A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
EP2504051B1 (en) 2009-11-25 2019-09-04 Boehringer Ingelheim International GmbH Nebulizer
WO2011160932A1 (en) 2010-06-24 2011-12-29 Boehringer Ingelheim International Gmbh Nebulizer
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
EP3030298B1 (en) 2013-08-09 2017-10-11 Boehringer Ingelheim International GmbH Nebulizer
EP2835146B1 (en) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Nebulizer
US10722666B2 (en) 2014-05-07 2020-07-28 Boehringer Ingelheim International Gmbh Nebulizer with axially movable and lockable container and indicator
EA032459B1 (ru) 2014-05-07 2019-05-31 Бёрингер Ингельхайм Интернациональ Гмбх Небулайзер
PL3139979T3 (pl) 2014-05-07 2023-12-27 Boehringer Ingelheim International Gmbh Jednostka, nebulizator i sposób

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1285023A (en) * 1968-08-09 1972-08-09 Novo Terapeutisk Labor As Improvements in or relating to injectable insulin preparations
US3758683A (en) * 1971-04-30 1973-09-11 R Jackson Insulin product

Also Published As

Publication number Publication date
MY7900169A (en) 1979-12-31
NO760118L (xx) 1976-07-16
SE7600284L (sv) 1976-07-16
MX4052E (es) 1981-11-24
EG11988A (en) 1978-06-30
DE2600971C2 (de) 1985-12-12
PL99927B1 (pl) 1978-08-31
IL48845A0 (en) 1976-03-31
YU8376A (en) 1982-06-30
PT64696B (fr) 1977-08-10
IN143279B (xx) 1977-10-29
AT362492B (de) 1981-05-25
GR58608B (en) 1977-11-10
GB1524431A (en) 1978-09-13
IE42395L (en) 1976-07-15
ATA21376A (de) 1980-10-15
JPS5946939B2 (ja) 1984-11-15
PT64696A (fr) 1976-02-01
HU175142B (hu) 1980-05-28
CH631625A5 (en) 1982-08-31
NL166464C (nl) 1981-08-17
ES444558A1 (es) 1977-05-16
OA05209A (fr) 1981-02-28
AR213088A1 (es) 1978-12-15
NL166464B (nl) 1981-03-16
BR7600206A (pt) 1976-08-31
IE42395B1 (en) 1980-07-30
DK140801B (da) 1979-11-19
AU1030776A (en) 1977-07-21
NL7600338A (nl) 1976-07-19
FI66751B (fi) 1984-08-31
FR2297634A1 (fr) 1976-08-13
IT1054211B (it) 1981-11-10
RO71576A (ro) 1980-12-30
DK140801C (xx) 1980-04-21
DE2600971A1 (de) 1976-07-22
IL48845A (en) 1981-06-29
ZA7658B (en) 1976-12-29
DK8375A (xx) 1976-07-16
FI66751C (fi) 1984-12-10
LU74175A1 (xx) 1977-03-18
BE837600A (fr) 1976-07-15
CA1094549A (en) 1981-01-27
JPS51125299A (en) 1976-11-01
DD124379A5 (xx) 1977-02-16
KE2919A (en) 1979-03-30
FR2297634B1 (xx) 1979-03-30
FI760058A (xx) 1976-07-16
CS208147B2 (en) 1981-08-31
SE437219B (sv) 1985-02-18
NO146698B (no) 1982-08-16
NO146698C (no) 1982-11-24

Similar Documents

Publication Publication Date Title
NZ179733A (en) Stable insulin preparation
GB1542947A (en) Syringe
HK20283A (en) Chair
YU131376A (en) Medical fluid-container
JPS5348392A (en) Syringe
JPS52136076A (en) Toaster
JPS522656A (en) Chair
GB1556251A (en) Chair
JPS5237176A (en) Ampule
JPS5273805A (en) Stable alminium alkokyside solusion and its preparation
JPS5215826A (en) Medical composition
JPS51126281A (en) Cytootoxic substance
GB1544669A (en) Chair
IL50667A0 (en) The preparation of4-alkyl-thiosemicarbazides
GB1541493A (en) Preparation of -acyl pyrroles
AU1508976A (en) Chair
JPS529638A (en) Tinnelectroplating solution
JPS51130425A (en) Colddwaterrsoluble preparations
GB1541710A (en) Anthelintic preparations
JPS5212070A (en) Chair
HU173776B (hu) Gerbicidnyj preparat soderzhahhij tiometil-aril-mochevinu
JPS51123833A (en) Novel medicine
JPS5245450A (en) Chair
JPS5261233A (en) Medical composition
JPS5367983A (en) Syringe